Two Sigma Securities’s Inovio Pharmaceuticals INO Stock Holding History

Two Sigma Securities’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.6K	Buy	+15,958	New	+$18.9K	﹤0.01%	1504
2025 Q3	–	Sell	-23,003	Closed	-$46.8K	–	1692
2025 Q2	$46.8K	Buy	+23,003	New	+$44.1K	0.01%	1117
2024 Q1	–	Sell	-9,038	Closed	-$55.3K	–	3261
2023 Q4	$55.3K	Buy	9,038 +1,503	+20%	+$7.42K	﹤0.01%	2589
2023 Q3	$35.2K	Sell	7,535 -1,897	-20%	-$10.5K	﹤0.01%	2510
2023 Q2	$50.5K	Buy	+9,432	New	+$76K	﹤0.01%	2392
2023 Q1	–	Sell	-1,880	Closed	-$35.2K	–	2950
2022 Q4	$35.2K	Buy	+1,880	New	+$42.6K	﹤0.01%	2206
2022 Q3	–	Sell	-4,172	Closed	-$87K	–	2840
2022 Q2	$87K	Buy	4,172 +1,942	+87%	+$54.7K	﹤0.01%	1777
2022 Q1	$96K	Buy	+2,230	New	+$100K	﹤0.01%	1809
2021 Q2	–	Sell	-1,431	Closed	-$159K	–	1591
2021 Q1	$159K	Buy	+1,431	New	+$188K	0.01%	668

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Securities's INO Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 15,958 shares worth $17.6K. The stake represents ﹤0.01% of the portfolio and ranks #1504 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in INO as recently as Q2 2025.

Two Sigma Securities first reported a position in INO in Q1 2021 and has held it in 9 quarters since. The position peaked at $159K in Q1 2021. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Two Sigma Securities held 15,958 shares of Inovio Pharmaceuticals worth $17.6K as of Q2 2026.
Inovio Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1504 holding.
Two Sigma Securities first reported a position in Inovio Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
Two Sigma Securities's Inovio Pharmaceuticals position peaked at $159K in Q1 2021.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.